their plasmalogen content ( 0-5 % of total phospholipid ) is significantly reduced compared with that of control cells from healthy donors ( 13-15 % of total phospholipid ) or of chrs fibroblasts supplemented with the plasmalogen precursor , hexadecylglycerol .
C0007634
cells
C0016030
fibroblasts